Early Access — free while we kick the tires
EdgarHawk

Rowland Charles A Jr

Director

Director
1 filing analyzed · 1 company · Latest 2025-10-28

Companies

Company Buys Sells Direction
Viking Therapeutics, Inc. VKTX 0 4 Net selling

Activity

October 2025
high
Sell
60,000 shares
$2,134,278
Significance 6/10

Director Rowland Charles A Jr sold 60,000 shares of VKTX at $35.57 (2.1M), reducing holdings 66.7%; stock down 55.2% from $78.03 high.

Director Rowland sold 60,000 shares (60.0K shares) at $35.57 on 2025-10-27, reducing his stake by 66.7% from 90,000 shares (90.0K shares) to 30,000 shares (30.0K shares). The transaction occurred when the stock was trading at $35.57, which is 55.2% below the 52-week high of $78.03, and the company reported net income of $-90,787,000.00 ($-90.8M) with $0.00 revenue in its latest quarter. Rowland's cross-ticker track record shows strong historical performance (2 prior buys with avg 90d return of +1731.4% and a 100% win rate), yet this represents a substantial reduction in his Viking position rather than accumulation, occurring during a period of significant stock depreciation and ongoing operating losses.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access